177 related articles for article (PubMed ID: 20510717)
21. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.
Hay ID
J Surg Oncol; 2006 Dec; 94(8):692-700. PubMed ID: 17131429
[TBL] [Abstract][Full Text] [Related]
22. [How good is the prognosis in differentiated thyroid gland carcinoma].
Ommer A; Bottel P; Stremmel W
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():192-5. PubMed ID: 9101828
[TBL] [Abstract][Full Text] [Related]
23. The role of total thyroidectomy in the management of differentiated thyroid cancer.
Stephenson BM; Wheeler MH; Clark OH
Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
[TBL] [Abstract][Full Text] [Related]
24. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
25. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
26. [Not Available].
Lenschow C; Lindner K; Müller AK; Barth P; Senninger N; Colombo-Benkmann M
Chirurg; 2016 Mar; 87(3):247-50. PubMed ID: 26223667
[No Abstract] [Full Text] [Related]
27. Update on recent developments in the therapy of differentiated thyroid cancer.
Middendorp M; Grünwald F
Semin Nucl Med; 2010 Mar; 40(2):145-52. PubMed ID: 20113682
[TBL] [Abstract][Full Text] [Related]
28. [Surgical therapy of differentiated thyroid gland carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Junginger T
Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
[TBL] [Abstract][Full Text] [Related]
29. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
32. Contemporary management of papillary carcinoma of the thyroid gland.
Rosenbaum MA; McHenry CR
Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
Francia G; Davì MV; Petroziello A; Sussi PL
Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
[TBL] [Abstract][Full Text] [Related]
34. Advances in the medical management of differentiated thyroid carcinoma and their impact on the surgical approach.
Van den Bruel A; Vauterin T; Poorten VV; Decallonne B
Acta Chir Belg; 2007 Jun; 107(3):271-8. PubMed ID: 17685252
[TBL] [Abstract][Full Text] [Related]
35. Thyroid peroxidase (TPO) as a tumor marker in the follow-up of differentiated thyroid carcinomas with surgical and ablative radioiodine therapy. An assessment after evaluation.
Franke WG; Zöphel K; Wunderlich G; Kühne A; Schimming C; Kropp J; Bredow J
Anticancer Res; 1999; 19(4A):2711-6. PubMed ID: 10470226
[TBL] [Abstract][Full Text] [Related]
36. Postoperative radioactive iodine administration for differentiated thyroid cancer patients.
Lepoutre-Lussey C; Deandreis D; Leboulleux S; Schlumberger M
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):363-71. PubMed ID: 25119656
[TBL] [Abstract][Full Text] [Related]
37. [Main trends and controversies in treatment of patients with diffuse toxic goiter and thyroid gland cancer].
Romanchishen AF; Vabalaĭte KV
Vestn Khir Im I I Grek; 2011; 170(3):58-63. PubMed ID: 21848241
[No Abstract] [Full Text] [Related]
38. Differentiated thyroid cancer: an update.
Wang TS; Roman SA; Sosa JA
Curr Opin Oncol; 2011 Jan; 23(1):7-12. PubMed ID: 20861795
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Follow-Up for Differentiated Thyroid Carcinoma Patients: A Reconsideration.
van der Wardt RA; Persoon AC; Klein Hesselink EN; Links TP
Thyroid; 2017 Mar; 27(3):475-476. PubMed ID: 28049373
[No Abstract] [Full Text] [Related]
40. Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography.
Durante C; Filetti S
J Clin Endocrinol Metab; 2011 Oct; 96(10):3059-61. PubMed ID: 21795452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
